IDO induces immunosuppression by allowing tumor to cells to escape T lymphocytes based on regulation the content of tryptophan in tumor microenvironment through tryptophan metabolism pathway in vitro and in vivo evidence, suggesting IDO inhibitors may be efficacious novel immunotherapy compounds [7, 8]. Here, IDO1 is linked to neoplasm.